Find your next paid study

Iterion TherapeuticsNCT05797805

~$10 – $8,750

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

Aberrant miRNA production has been linked to a wide range of human cancers and shown to play important roles in their genesis and growth. These miRNA can be de…

Pancreatic Cancer Stage IIIPancreatic Cancer Stage IVPancreatic Ductal Adenocarcinoma+1 more

Nuvance HealthNCT04406831

~$10 – $1,125

Phase 1

A Phase 1, Prospective, Standard Dose Escalation Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)

The purpose of this study is to determine whether a new treatment combining radiation therapy with PCX12 is safe and tolerable.

Pancreatic Adenocarcinoma

Haoming (Carl) QiuNCT06217666

~$10 – $7,500

Invasive Breast CancerInflammatory Breast Cancer Stage IIIHER2-positive Breast Cancer+2 more

TRUDI: A Phase II Study of Neoadjuvant Trastuzumab Deruxtecan and Durvalumab for Stage III, HER2-expressing Inflammatory Breast Cancer

The purpose of this study is to test the safety and effectiveness of an investigational drug combination (trastuzumab deruxtecan and durvalumab) to learn wheth…

Filipa Lynce, MDNCT05795101

~$10 – $7,500

Phase 1

A Phase 1/2, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of INX-315 in Patients With Advanced Cancer

Incyclix Bio (Incyclix) is developing INX-315 as an oral, small molecule inhibitor of cyclin dependent kinase 2 (CDK2) for the treatment of human cancers. This…

Breast CancerBreast Cancer MetastaticHormone Receptor Positive Tumor+6 more

~$10 – $8,750

Incyclix BioNCT05735080

Breast CancerTriple Negative Breast Cancer (TNBC)HER2-Negative Breast Carcinoma+1 more

Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer

This is a prospective radiation dose-finding, phase 2 expansion study of the Triple Negative (TN) cohort of the multicenter randomized study P-RAD (A Randomize…

UNC Lineberger Comprehensive Cancer CenterNCT07276880

Lung Non-Small Cell Carcinoma

A Phase II Study of Amivantamab SC (Subcutaneous) in Participants With MET Amplification-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)

This phase II Expanded Lung-MAP treatment trial tests how well amivantamab-subcutaneous (SC) works in treating patients patients with MET amplification non-sma…

SWOG Cancer Research NetworkNCT06116682

~$10 – $7,500

Thyroid CancerThyroid CarcinomaMetastatic Thyroid Cancer+3 more

Restoration of Radioiodine Uptake with Selpercatinib in RET Fusion-Positive Radioiodine-Refractory Thyroid Cancer: a Phase 2 Study Performed in Collaboration with the International Thyroid Oncology Group (ITOG)

This research is being done to determine the efficacy of selpercatinib to restore radioactive iodine (I-131 NaI) uptake and allow for I-131 treatment in people…

Massachusetts General HospitalNCT05668962

Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer

This is a correlative (lab-based) study aiming to identify protein markers in urine extracellular vesicles (EVs) that can be used to develop non-invasive molec…

Renal Cell CarcinomaClear-cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+2 more

Cigarette Smoking-Related Carcinoma

~$10 – $750

Mayo ClinicNCT07243067

Phase 4

PISCES I: Precision Implemented Smoking Cessation Evaluation Study

This phase IV trial investigates how to personalize treatments (such as medications and/or counseling) for quitting smoking based on the unique character trait…

M.D. Anderson Cancer CenterNCT04604509

Observational

Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma (PHOLIPANC) Following Pre-operative Liposomal Irinotecan Combined With Oxaliplatin and 5-Fluoracil/Folinic Acid (NALIRIFOX): A Phase II Open-Label Single Arm Trial

This is a clinical trial that tests a surgical treatment. Everyone in the study will get the same treatment, and there is no comparison or placebo group. Pati…

Adenocarcinoma of the Pancreas

The University of Texas Health Science Center at San AntonioNCT07340151

Phase 1

Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma

Testing an investigational cancer therapy called TGFBR-2 KO CD70 CAR NK cell therapy.

Clear Cell CarcinomaPhase 1Growth Factor